Furthermore, TRPV4 antagonists have shown therapeutic potential in experiment animal models for a range of conditions, including heart failure, edema, pain, gastrointestinal disorders, lung diseases, and various cancers [57]. This evidence concerns the gene TRPV4 and cancer.